Significant efficacy in a phase 2 study of NKTR-102, a novel polymer conjugate of Irinotecan, in patients with pre-treated metastatic breast cancer (MBC)

Awada, Ahmad; Chan, Stephan; JERUSALEM, Guy; Coleman, Robert E; Huizing, Manon; Mehdi, Aminder; O'Reilly, Susan M; Hamm, John T; Patel, Tejal; Hannah, Alison L; Masuoka, Lorianne K; Garcia, Agustin A; Perez, Edith A

Paper published in a journal (Scientific congresses and symposiums)

Awada, Ahmad; Chan, Stephan; JERUSALEM, Guy et al.

2010 • In Cancer Research, 70 (24), p. 6-11-01

Peer Reviewed verified by ORBi

Permalink
https://hdl.handle.net/2268/175362

Files (3)Send to Details Statistics Bibliography Similar publications

Files

Full Text

Significant efficacy in a phase 3 study of NKTR-102 ... poster.pdf

Publisher postprint (846.44 kB)

Request a copy

Annexes

Significant efficacy in a phase 2 study of NKTR-102 ... dias'.pdf

Publisher postprint (810.27 kB)

Request a copy

Significant efficacy in a phase 2 study of NKTR-102 ... - abstract.pdf

Publisher postprint (749.24 kB)

Request a copy

All documents in ORBi are protected by a user license.

Send to

RIS BibTex APA Chicago Permalink X Linkedin

Details

Disciplines :

Oncology

Author, co-author :

Awada, Ahmad; Institut Jules Bordet, Brussels, Belgium

Chan, Stephan; Nottingham City Hospital, Nottingham, United Kingdom

JERUSALEM, Guy ; Centre Hospitalier Universitaire de Liège - CHU > Oncologie médicale

Coleman, Robert E; Weston Park Hospital, Sheffield, United Kingdom

Huizing, Manon; UZ Antwerpen, Antwerp, Belgium

Mehdi, Aminder; Stockton Hematology/Oncology, Stockton, California, United States

O'Reilly, Susan M; Clatterbridge Centre for Oncology, Bebington, United Kingdom

Hamm, John T; Louisville Oncology Research, Louisville, Kentucky, United States

Patel, Tejal; Mayo Clinic, Jacksonville, Florida, United States

Hannah, Alison L; Nektar Therapeutics, San Francisco, California, United States and the NKTR-102 Study Group

More authors (3 more)

Language :

English

Title :

Significant efficacy in a phase 2 study of NKTR-102, a novel polymer conjugate of Irinotecan, in patients with pre-treated metastatic breast cancer (MBC)

Publication date :

December 2010

Event name :

33rd Annual CTRC-AACR San Antonio Breast Cancer Symposium

Event organizer :

SABCC

Event place :

San Antonio, United States

Event date :

December 8-12, 2010

Audience :

International

Journal title :

Cancer Research

ISSN :

0008-5472

eISSN :

1538-7445

Publisher :

American Association for Cancer Research, Inc. (AACR), Baltimore, United States - Maryland

Volume :

Issue :

Pages :

abstract P6-11-01

Peer reviewed :

Peer Reviewed verified by ORBi

Available on ORBi :

since 19 December 2014

Statistics

Number of views

56 (1 by ULiège)

Number of downloads

0 (0 by ULiège)

More statistics